On April 8, 2024 PharmaMar (MSE:PHM), world leader in the research, development and commercialization of marine-derived anticancer drugs, reported that the Company will participate in the 23rd Annual Needham Virtual Healthcare Conference taking place virtually on April 8-11, 2024 (Press release, PharmaMar, APR 8, 2024, View Source [SID1234641876]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

PharmaMar’s management team, will meet with institutional investors, private equity and venture capital investors, and participate in a fireside chat with Needham’s Research Analyst on April 9th at 08:45 Eastern (14:45 CET).